Antitumor Activity of Ficlatuzumab in Combination with Tivozanib On Primary Human Renal Cell Carcinoma Xenografts

被引：0
|
作者：
Meetze, K. [1 ]
Connolly, K. [1 ]
Feng, B. [1 ]
Rideout, W. [1 ]
Gyuris, J. [1 ]
Han, M. [1 ]
机构：
[1] AVEO Pharmaceut Inc, Drug Discovery, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
301
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [1] Antitumor Activity of Ficlatuzumab in Combination with Cetuximab On Squamous Cell Carcinomas of the Head and Neck
    Meetze, K.
    Connolly, K.
    Clark, K.
    Gyuris, J.
    Han, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 92 - 92
  • [2] Tivozanib for the treatment of renal cell carcinoma
    Santoni, Matteo
    Massari, Francesco
    Piva, Francesco
    Carrozza, Francesco
    Di Nunno, Vincenzo
    Cimadamore, Alessia
    Martignetti, Angelo
    Montironi, Rodolfo
    Battelli, Nicola
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (09) : 1021 - 1025
  • [3] Tivozanib in the treatment of renal cell carcinoma
    Hepgur, Mehmet
    Sadeghi, Sarmad
    Dorff, Tanya B.
    Quinn, David I.
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 139 - 148
  • [4] NOVEL COMBINATION SHOWS STRONG ANTITUMOR ACTIVITY IN METASTATIC RENAL CELL CARCINOMA
    Kahl, Kristie L.
    ONCOLOGY-NEW YORK, 2019, 33 (12): : 487 - 487
  • [5] Tivozanib for the treatment of advanced renal cell carcinoma
    Chatzkel, Jonathan
    Ramnaraign, Brian
    Sonpavde, Guru
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (10) : 1135 - 1142
  • [6] Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma
    Nosov, Dmitry A.
    Esteves, Brooke
    Lipatov, Oleg N.
    Lyulko, Alexei A.
    Anischenko, A. A.
    Chacko, Raju T.
    Doval, Dinesh C.
    Strahs, Andrew
    Slichenmyer, William J.
    Bhargava, Pankaj
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1678 - 1685
  • [7] Antitumor activity of doxorubicin in combination with docetaxel against human breast cancer xenografts
    Egawa, T
    Kubota, T
    Suto, A
    Otani, Y
    Furukawa, T
    Saikawa, Y
    Watanabe, M
    Kumai, K
    Kitajima, M
    IN VIVO, 2003, 17 (01): : 23 - 28
  • [8] Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma
    Köpf-Maier, P
    ANTICANCER RESEARCH, 1999, 19 (1A) : 493 - 504
  • [9] Differential transplantability of human endothelial cells in colorectal cancer and renal cell carcinoma primary xenografts
    Sanz, Laura
    Cuesta, Angel M.
    Salas, Clara
    Corbacho, Cesar
    Bellas, Carmen
    Alvarez-Vallina, Luis
    LABORATORY INVESTIGATION, 2009, 89 (01) : 91 - 97
  • [10] Tivozanib: A New Hope for Treating Renal Cell Carcinoma
    Passi, Indu
    Billowria, Koushal
    Kumar, Bhupinder
    Chawla, Pooja A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (05) : 562 - 570
12345